Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

December 31, 2026

Conditions
AsthmaCOPD
Interventions
DRUG

prednisolone

Prednisolone oral tablets (10 mg active ingredient per tablet) once a day at a dose of 0.5mg/kg bodyweight, during 14 days.

Trial Locations (1)

17177

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

University of Athens

OTHER

collaborator

University Hospital of Crete

OTHER

collaborator

Università degli Studi di Ferrara

OTHER

collaborator

University Ghent

OTHER

collaborator

Pulmonary Research Institute Grosshansdorf

UNKNOWN

collaborator

Leiden University Medical Center

OTHER

collaborator

Imperial College London

OTHER

collaborator

Université Montpellier

OTHER

collaborator

"Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy"

OTHER_GOV

collaborator

University of Southampton

OTHER

collaborator

Jagiellonian University

OTHER

lead

Karolinska Institutet

OTHER